Based on emerging research it seems possible to precisely starve off tumors quickly is by precisely removing the nutrients they feed off of, in a way that is nutritionally sustainable to the patient. We’ve seen a number of companies approach prescribed diets for cancer thus far is such: they approach a few cancers with a body of pre-clinical diet research around a few therapeutic targets – generally some type of specific amino acid.

For other cancers, it seems that intermittent fasting becomes even more relevant when it replicates the effects of drugs like Rapamycin which may be one of the few drugs to have any effect on some less common cancers like Chordoma. Ideally, the more we map metabolic pathways, the better we can become at targeting specific parts of them through dietary interventions and others to disable cancers. We are looking to find companies going through clinical trials in this space.